289 related articles for article (PubMed ID: 16973570)
1. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
Daddario-DiCaprio KM; Geisbert TW; Geisbert JB; Ströher U; Hensley LE; Grolla A; Fritz EA; Feldmann F; Feldmann H; Jones SM
J Virol; 2006 Oct; 80(19):9659-66. PubMed ID: 16973570
[TBL] [Abstract][Full Text] [Related]
2. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
3. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
4. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
Front Immunol; 2018; 9():3071. PubMed ID: 30723475
[TBL] [Abstract][Full Text] [Related]
5. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
6. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
Daddario-DiCaprio KM; Geisbert TW; Ströher U; Geisbert JB; Grolla A; Fritz EA; Fernando L; Kagan E; Jahrling PB; Hensley LE; Jones SM; Feldmann H
Lancet; 2006 Apr; 367(9520):1399-404. PubMed ID: 16650649
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
[TBL] [Abstract][Full Text] [Related]
8. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
Woolsey C; Geisbert JB; Matassov D; Agans KN; Borisevich V; Cross RW; Deer DJ; Fenton KA; Eldridge JH; Mire CE; Geisbert TW
J Infect Dis; 2018 Nov; 218(suppl_5):S582-S587. PubMed ID: 29939296
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.
Cross RW; Fenton KA; Geisbert JB; Ebihara H; Mire CE; Geisbert TW
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S258-70. PubMed ID: 26092858
[TBL] [Abstract][Full Text] [Related]
10. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
Wang D; Schmaljohn AL; Raja NU; Trubey CM; Juompan LY; Luo M; Deitz SB; Yu H; Woraratanadharm J; Holman DH; Moore KM; Swain BM; Pratt WD; Dong JY
Vaccine; 2006 Apr; 24(15):2975-86. PubMed ID: 16530297
[TBL] [Abstract][Full Text] [Related]
11. Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
Wang D; Hevey M; Juompan LY; Trubey CM; Raja NU; Deitz SB; Woraratanadharm J; Luo M; Yu H; Swain BM; Moore KM; Dong JY
Virology; 2006 Sep; 353(2):324-32. PubMed ID: 16820184
[TBL] [Abstract][Full Text] [Related]
12. Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease.
Marzi A; Jankeel A; Menicucci AR; Callison J; O'Donnell KL; Feldmann F; Pinski AN; Hanley PW; Messaoudi I
Front Immunol; 2021; 12():774026. PubMed ID: 34777392
[TBL] [Abstract][Full Text] [Related]
13. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.
Geisbert TW; Bailey M; Geisbert JB; Asiedu C; Roederer M; Grazia-Pau M; Custers J; Jahrling P; Goudsmit J; Koup R; Sullivan NJ
J Virol; 2010 Oct; 84(19):10386-94. PubMed ID: 20660192
[TBL] [Abstract][Full Text] [Related]
14. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
Mire CE; Geisbert JB; Agans KN; Satterfield BA; Versteeg KM; Fritz EA; Feldmann H; Hensley LE; Geisbert TW
PLoS One; 2014; 9(4):e94355. PubMed ID: 24759889
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
16. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
[TBL] [Abstract][Full Text] [Related]
17. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
Woolsey C; Cross RW; Agans KN; Borisevich V; Deer DJ; Geisbert JB; Gerardi C; Latham TE; Fenton KA; Egan MA; Eldridge JH; Geisbert TW; Matassov D
PLoS Negl Trop Dis; 2022 May; 16(5):e0010433. PubMed ID: 35622847
[TBL] [Abstract][Full Text] [Related]
18. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).
Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S
Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636
[TBL] [Abstract][Full Text] [Related]
19. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
Geisbert TW; Daddario-Dicaprio KM; Geisbert JB; Reed DS; Feldmann F; Grolla A; Ströher U; Fritz EA; Hensley LE; Jones SM; Feldmann H
Vaccine; 2008 Dec; 26(52):6894-900. PubMed ID: 18930776
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent enhancement of Marburg virus infection.
Nakayama E; Tomabechi D; Matsuno K; Kishida N; Yoshida R; Feldmann H; Takada A
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S978-85. PubMed ID: 21987779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
